Статті в журналах з теми "M. tuberculosis - Rifampicin"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "M. tuberculosis - Rifampicin".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Danlami, Mohammed Bashar, Basiru Aliyu, and Grace Samuel. "INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA." African Journal of Infectious Diseases 15, no. 1 (December 15, 2020): 47–52. http://dx.doi.org/10.21010/ajid.v15i1.6.
Повний текст джерелаde la Iglesia, Agustina I., Emma J. Stella, and Héctor R. Morbidoni. "Comparison of the Performances of Two In-House Rapid Methods for Antitubercular Drug Susceptibility Testing." Antimicrobial Agents and Chemotherapy 53, no. 2 (November 17, 2008): 808–10. http://dx.doi.org/10.1128/aac.00960-08.
Повний текст джерелаАХМЕТОВА, А. Ж., Ж. М. АБИЛОВА, Г. Н. ЖАРЫЛҚАСЫН, А. Р. АКИЛЬЖАНОВА та У. А. КОЖАМКУЛОВ. "ҚАЗАҚСТАНДА ТАРАЛҒАН РИФАМПИЦИН-ТӨЗІМДІ M. TUBERCULOSIS КЛИНИКАЛЫҚ ИЗОЛЯТТАРЫНЫҢ ГЕНЕТИКАЛЫҚ СИПАТТАМАСЫ". Vestnik, № 1(64) (14 квітня 2023): 53–65. http://dx.doi.org/10.53065/j5985-7576-8270-u.
Повний текст джерелаGautam, Praveen B., Ashwini Mishra, and Santosh Kumar. "Prevalence of rifampicin resistant mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients in eastern Uttar Pradesh: a cross sectional study." International Journal Of Community Medicine And Public Health 5, no. 6 (May 22, 2018): 2271. http://dx.doi.org/10.18203/2394-6040.ijcmph20182039.
Повний текст джерелаSanzhakov, M. A., O. M. Ipatova, T. I. Torkhovskaya, E. G. Tikhonova, N. V. Medvedeva, T. S. Zakharova, and V. N. Prozorovskiy. "Increase of antituberculosis efficiency of rifampicin embedded into phospholipid nanoparticles with sodium oleate." Biomeditsinskaya Khimiya 64, no. 6 (2018): 505–10. http://dx.doi.org/10.18097/pbmc20186406505.
Повний текст джерелаNotopuro, P. B., J. Nugraha, and H. Notopuro. "DETEKSI MOLEKUL MUTASI GEN rpoB MYCOBACTERIUM TUBERCULO SIS PADA DAHAK DENGAN POL YME RASE CHAIN REACTION DAN SINGLE STRAND CONFORMATION POLYMORPHISM." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 16, no. 2 (March 16, 2018): 81. http://dx.doi.org/10.24293/ijcpml.v16i2.973.
Повний текст джерелаN. Djide, Nana Juniarti, M. Natsir Djide, Muhammad Nur Amir, and Sartini Sartini. "Aktivitas Antibakteri Ekstrak Kelopak Bunga Rosella Terenkapsulasi Maltodekstrin dan Sinergitasnya dengan Isoniazida dan Rifampisin Terhadap Mycobacterium tuberculosis H37rv." Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) 5, no. 2 (October 15, 2019): 117. http://dx.doi.org/10.22487/j24428744.0.v0.i0.12946.
Повний текст джерелаN. Djide, Nana Juniarti, M. Natsir Djide, Muhammad Nur Amir, and Sartini Sartini. "Aktivitas Antibakteri Ekstrak Kelopak Bunga Rosella Terenkapsulasi Maltodekstrin dan Sinergitasnya dengan Isoniazida dan Rifampisin Terhadap Mycobacterium tuberculosis H37rv." Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) 5, no. 2 (October 15, 2019): 117–23. http://dx.doi.org/10.22487/j24428744.2019.v5.i2.12946.
Повний текст джерелаMohiuddin, Md, and J. Ashraful Haq. "First Line Anti-Tubercular Drug Resistance Pattern of Mycobacterium Tuberculosis Isolated From Specialized Hospitals of Dhaka City." Ibrahim Medical College Journal 8, no. 2 (February 4, 2016): 41–46. http://dx.doi.org/10.3329/imcj.v8i2.26677.
Повний текст джерелаKashyap, Bineeta, Nisha Goyal, Puneeta Hyanki, NP Singh, and Ashwani Khanna. "Cartridge-based nucleic acid amplification test: a novel rapid diagnostic tool to study the burden of tuberculosis from a tertiary care hospital." Tropical Doctor 49, no. 4 (July 10, 2019): 274–81. http://dx.doi.org/10.1177/0049475519859958.
Повний текст джерелаZahoor, Danish, Shameem Wani, and Zaffer Nowshad Wani. "Evaluation of cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampicin resistance in clinical specimen." International Journal of Research in Medical Sciences 7, no. 6 (May 29, 2019): 2121. http://dx.doi.org/10.18203/2320-6012.ijrms20192484.
Повний текст джерелаLaskar, Nourjahan, Md Akram Hossain, Jannatul Fardows, and Mominur Rahman. "GeneXpert MTB/RIF Assay for Rapid Identification of Mycobacterium Tuberculosis and Rifampicin Resistance Directly from Sputum Sample." Journal of Enam Medical College 7, no. 2 (June 4, 2017): 86–89. http://dx.doi.org/10.3329/jemc.v7i2.32653.
Повний текст джерелаHuey, Lee Lih, Chua Wei Chuan, Zeti Norfidiyati Ayub Salmuna, Norazmi Mohd Nor, Alwi Muhd Besari and Chan, and Yean Yean. "A novel two-codon deletion at codon 508 and 509 of the rpoB gene in pulmonary tuberculosis and HIV co-infection: A case report." Pakistan Journal of Medical and Health Sciences 16, no. 7 (July 30, 2022): 201–2. http://dx.doi.org/10.53350/pjmhs22167201.
Повний текст джерелаTesic, Jelena, Zorica Lepsanovic, and Veljko Mirovic. "Evaluation of usefulness of single-strand conformation polymorphism method for rapid detection of rifampicin-resistant mycobacterium tuberculosis." Vojnosanitetski pregled 61, no. 2 (2004): 169–72. http://dx.doi.org/10.2298/vsp0402169t.
Повний текст джерелаRiwu, Audrey Gracelia, Jusak Nugaraha, and Yoes Prijatna Dachlan. "DIFFERENCES OF INTERLEUKIN-18 AND INTERLEUKIN-10 LEVELS IN RIFAMPICIN RESISTANT AND RIFAMPICIN SENSITIVE PULMONARY TUBERCULOSIS PATIENTS IN DR. SOETOMO HOSPITAL SURABAYA." Indonesian Journal of Tropical and Infectious Disease 8, no. 2 (July 31, 2020): 116. http://dx.doi.org/10.20473/ijtid.v8i2.10959.
Повний текст джерелаJiang, Haiqin, Lemuel Tsang, Hongsheng Wang, and Changhong Liu. "IFI44L as a Forward Regulator Enhancing Host Antituberculosis Responses." Journal of Immunology Research 2021 (October 20, 2021): 1–12. http://dx.doi.org/10.1155/2021/5599408.
Повний текст джерелаZeng, Sheng, Dong Yang, Céline Rens, and Véronique Fontaine. "The Mycobacterium bovis BCG GroEL1 Contributes to Isoniazid Tolerance in a Dormant-Like State Model." Microorganisms 11, no. 2 (January 21, 2023): 286. http://dx.doi.org/10.3390/microorganisms11020286.
Повний текст джерелаSabaté, M. Betriu, A. González-Rodríguez, A. Guàrdia, E. Pérez-Macho, A. Alvarez Pedrero, S. Acebillo, J. A. Monreal, D. Palao Vidal, and J. Labad. "Pharmacokinetic interactions of psychotropic medications in patients with schizophrenia suffering from atypical mycobacterial infections." European Psychiatry 64, S1 (April 2021): S649—S650. http://dx.doi.org/10.1192/j.eurpsy.2021.1725.
Повний текст джерелаRahman, Fahmida, Sadia Sharmin, Md Mustafa Kamal, and Md Ruhul Amin Miah. "Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients." Ibrahim Medical College Journal 7, no. 1 (January 20, 2014): 9–11. http://dx.doi.org/10.3329/imcj.v7i1.17741.
Повний текст джерелаMurthy, Neetha S., Sanjeev Nair, PK Ramya, Renu Susan George, B. Ravikrishnan, M. Sunil Kumar, Sairu Philip, PS Rakesh, and Shibu Balakrishnan. "Drug-resistant Tuberculosis: First Line Drug Resistance Pattern among Mycobacterium Tuberculosis Strains Isolated from a Reference Laboratory in Kerala State, India." Journal of Pure and Applied Microbiology 15, no. 4 (October 4, 2021): 1882–91. http://dx.doi.org/10.22207/jpam.15.4.09.
Повний текст джерелаGarg, Saurabh, Rakesh Kumar, Dennis Kunimoto, and Gina R. Rayat. "Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds." Molecules 27, no. 19 (October 9, 2022): 6714. http://dx.doi.org/10.3390/molecules27196714.
Повний текст джерелаCoban, Ahmet Yilmaz. "A novel agar base medium for drug susceptibility testing of Mycobacterium tuberculosis isolates." Future Microbiology 16, no. 13 (September 2021): 949–53. http://dx.doi.org/10.2217/fmb-2021-0032.
Повний текст джерелаZhurilo, A. A., A. I. Barbova, Yu A. Cherednik, P. S. Trofimova, S. V. Mironchenko, O. V. Pavlova, A. V. Chernov, and L. M. Sladkova. "COMPARISON OF GENEXPERT MTB/RIF AND GENOTYPE SYSTEMS WITH MTBDRPLUS STRIPS FOR DETECTION OF MUTATIONS THAT ARE ASSOCIATED WITH M. TUBERCULOSIS RESISTANCE TO RIFAMPICIN IN TUBERCULOSIS." Ukrainian Pulmonology Journal 30, no. 4 (2022): 34–41. http://dx.doi.org/10.31215/2306-4927-2022-30-4-34-41.
Повний текст джерелаKumar Sah, Ranjit, Dwij Raj Bhatta, Gokarna Raj Ghimire, Bhuwaneswor Prasad Kandel, Bishnu Raj Tiwari, and Jeevan Bahadur Sherchand. "Evaluation of Nitrate Reductase Assay For Rapid Detection of Drug Resistant Tuberculosis." Journal of Health and Allied Sciences 3, no. 1 (November 24, 2019): 44–46. http://dx.doi.org/10.37107/jhas.53.
Повний текст джерелаAndreevskaya, S. N., T. G. Smirnova, E. E. Larionova, I. Yu Andrievskaya, L. N. Chernousova, and A. Ergeshov. "Isoniazid-resistant Mycobacterium tuberculosis: prevalence, resistance spectrum and genetic determinants of resistance." Bulletin of Russian State Medical University, no. (1)2020 (January 12, 2020): 21–26. http://dx.doi.org/10.24075/brsmu.2020.001.
Повний текст джерелаSantos, Nathally C. de S., Regiane B. de L. Scodro, Dayane CB Leal, Silvia MT do Prado, Daniela F. Micheletti, Eloísa G. Sampiron, Giovana F. Costacurta, et al. "Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis." Future Microbiology 15, no. 2 (January 2020): 107–14. http://dx.doi.org/10.2217/fmb-2019-0050.
Повний текст джерелаSah, Ranjit Kumar, DR Bhatta, GR Ghimire, BP Kandel, BR Tiwari, and JB Sherchand. "Evaluation of Nitrate Reductase Assay for Rapid Detection of Drug Resistant Tuberculosis." SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS 9, no. 2 (April 23, 2013): 4–8. http://dx.doi.org/10.3126/saarctb.v9i2.7971.
Повний текст джерелаAl-Madhagi, Anwar K., Khaled A. Al-Moyed, and Ahmed M. Al-Haddad. "Resistance of anti-tuberculosis drugs among pulmonary tuberculosis patients in Yemen." Journal of the Faculty of Medicine Baghdad 55, no. 3 (July 1, 2013): 250–53. http://dx.doi.org/10.32007/jfacmedbagdad.553625.
Повний текст джерелаSuhas Kulkarni, Gauri, and Chetan Mahajan. "Resistance to Isoniazid and Rifampicin and Factors Associated with Resistance Among MDR TB Patients Visiting DOTS PLUS Site." MVP Journal of Medical Sciences 4, no. 1 (May 22, 2017): 14. http://dx.doi.org/10.18311/mvpjms/0/v0/i0/14782.
Повний текст джерелаSolari, L., D. Santos-Lazaro, and Z. M. Puyen. "Mutations in Mycobacterium tuberculosis Isolates with Discordant Results for Drug-Susceptibility Testing in Peru." International Journal of Microbiology 2020 (April 7, 2020): 1–5. http://dx.doi.org/10.1155/2020/8253546.
Повний текст джерелаCaminero, Jose, and Charles Daley. "Management of Multidrug-Resistant Tuberculosis." Seminars in Respiratory and Critical Care Medicine 39, no. 03 (June 2018): 310–24. http://dx.doi.org/10.1055/s-0038-1661383.
Повний текст джерелаAl-Mutairi, Noura M., Suhail Ahmad, Eiman Mokaddas, and Sahal Al-Hajoj. "First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB." PLOS ONE 17, no. 10 (October 20, 2022): e0276487. http://dx.doi.org/10.1371/journal.pone.0276487.
Повний текст джерелаMADANIA, AMMAR, MAYA HABOUS, HANA ZARZOUR, IFAD GHOURY, and BAREA HEBBO. "Characterization of Mutations Causing Rifampicin and Isoniazid Resistance of Mycobacterium tuberculosis in Syria." Polish Journal of Microbiology 61, no. 1 (2012): 23–32. http://dx.doi.org/10.33073/pjm-2012-003.
Повний текст джерелаSalina, T. Yu, and T. I. Morozova. "Prevalence and Patterns of Gene Mutations Associated with <i>M. tuberculosis</i> Resistance to Isoniazid and Rifampicin in Patients with Different Clinical Manifestations of Tuberculosis." Tuberculosis and Lung Diseases 101, no. 1 (March 4, 2023): 28–33. http://dx.doi.org/10.58838/2075-1230-2023-101-1-28-33.
Повний текст джерелаKrajewska-Wędzina, Monika, Anna Zabost, Ewa Augustynowicz-Kopeć, Marcin Weiner, and Krzysztof Szulowski. "Evaluation of susceptibility to antimycobacterial drugs in Mycobacterium tuberculosis complex strains isolated from cattle in Poland." Journal of Veterinary Research 61, no. 1 (March 1, 2017): 23–26. http://dx.doi.org/10.1515/jvetres-2017-0003.
Повний текст джерелаAdmassu, Wasihun, Birhanu Ayelign, Gemeda Abebe, and Mulualem Tadesse. "Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia." PLOS ONE 17, no. 1 (January 27, 2022): e0262929. http://dx.doi.org/10.1371/journal.pone.0262929.
Повний текст джерелаKalani, Komal, Vinita Chaturvedi, Priyanka Trivedi, Sudeep Tondon, and Santosh Kumar Srivastava. "Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents." Current Topics in Medicinal Chemistry 19, no. 8 (June 3, 2019): 594–99. http://dx.doi.org/10.2174/1568026619666190304142802.
Повний текст джерелаUmpeleva, T. V., E. A. Mazurina, D. V. Vakhrusheva, and N. I. Eremeeva. "Comparison of Different Methods for Drug Susceptibility Testing of Mycobacterium tuberculosis to Rifampicin." Tuberculosis and Lung Diseases 100, no. 1 (February 11, 2022): 41–48. http://dx.doi.org/10.21292/2075-1230-2022-100-1-41-48.
Повний текст джерелаDiriba, Getu, Abebaw Kebede, Habteyes Hailu Tola, Ayinalem Alemu, Bazezew Yenew, Shewki Moga, Desalegn Addise, et al. "Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia." SAGE Open Medicine 10 (January 2022): 205031212210982. http://dx.doi.org/10.1177/20503121221098241.
Повний текст джерелаKazakova, Oxana, Roxana Racoviceanu, Anastasiya Petrova, Marius Mioc, Adrian Militaru, Lucreția Udrescu, Mihai Udrescu, et al. "New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design." International Journal of Molecular Sciences 22, no. 22 (November 21, 2021): 12542. http://dx.doi.org/10.3390/ijms222212542.
Повний текст джерелаSanzhakov, M. A., O. M. Ipatova, V. N. Prozorovskiy, N. V. Medvedeva, and T. I. Torkhovskaya. "Interaction of rifampicin embedded in phospholipid nanoparticles with blood plasma lipoproteins." Biomeditsinskaya Khimiya 60, no. 3 (2014): 348–53. http://dx.doi.org/10.18097/pbmc20146003348.
Повний текст джерелаMohamad, Suriyati, Nur Najihah Ismail, Hasnah Osman, Habibah A Wahab, and Thaigarajan Parumasivam. "In Vitro Interactions of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (Dc. Ex Nees) Stapf. and Tabernaemontana coronaria (L.) Willd. with First-Line Anti-Tuberculosis Drugs Against Mycobacterium tuberculosis H37rv." Malaysian Journal of Pharmaceutical Sciences 19, no. 2 (November 23, 2021): 171–78. http://dx.doi.org/10.21315/mjps2021.19.2.11.
Повний текст джерелаSarkar, Sampa, and Dhiman Sarkar. "Potential Use of Nitrate Reductase as a Biomarker for the Identification of Active and Dormant Inhibitors of Mycobacterium tuberculosis in a THP1 Infection Model." Journal of Biomolecular Screening 17, no. 7 (May 9, 2012): 966–73. http://dx.doi.org/10.1177/1087057112445485.
Повний текст джерелаKumar, Vipul, Jyoti Yadav, Aparna Parmar, Ritu Aggarwal, and K. B. Gupta. "Study of rifampicin resistance among newly diagnosed pulmonary tuberculosis patients with type 2 diabetes mellitus: a prospective observational study." International Journal of Research in Medical Sciences 9, no. 7 (June 25, 2021): 2035. http://dx.doi.org/10.18203/2320-6012.ijrms20212526.
Повний текст джерелаDey, Abhinav, Amit Kumar Verma, and Dipankar Chatterji. "Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin." Microbiology 156, no. 3 (March 1, 2010): 873–83. http://dx.doi.org/10.1099/mic.0.033670-0.
Повний текст джерелаDo, Thi Thuy, Jerónimo Rodríguez-Beltran, Esmeralda Cebrián-Sastre, Alexandro Rodríguez-Rojas, Alfredo Castañeda-García, and Jesús Blázquez. "Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in Mycobacterium smegmatis." Antibiotics 11, no. 4 (April 12, 2022): 509. http://dx.doi.org/10.3390/antibiotics11040509.
Повний текст джерелаBondarenko, V. N., V. A. Shtanze, and L. V. Zolotukhina. "CHARACTERISTICS OF <i>M.TUBERCULOSIS</i> DRUG RESISTANCE DETERMINED BY MOLECULAR GENETIC AND PHENOTYPIC METHODS." Health and Ecology Issues, no. 3 (September 28, 2018): 61–66. http://dx.doi.org/10.51523/2708-6011.2018-15-3-12.
Повний текст джерелаDarma, Surya, Angga Ambara, Abu Tholib Aman, Luthvia Annisa, Nurrokhman, Titik Nuryastuti, and Tri Wibawa. "High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients." PLOS ONE 15, no. 11 (November 19, 2020): e0242542. http://dx.doi.org/10.1371/journal.pone.0242542.
Повний текст джерелаBourama Kané, Korotoumou Wélé Diallo, Boubacar Mami Touré, Oumou Koné, Guédiouma Dembélé, Sow Djénéba Sylla, Modibo Mariko, et al. "Bacilliferous pulmonary tuberculosis of the infant: Report of 3 cases in the pediatrics department of the hospital of Mali." International Journal of Science and Research Archive 1, no. 1 (November 30, 2020): 018–25. http://dx.doi.org/10.30574/ijsra.2020.1.1.0018.
Повний текст джерелаKhan, Javaid, Najmul Islam, Nadya Ajanee, and Wasim Jafri. "Drug Resistance of Mycobacterium Tuberculosis in Karachi, Pakistan." Tropical Doctor 23, no. 1 (January 1993): 13–14. http://dx.doi.org/10.1177/004947559302300107.
Повний текст джерела